Medpace Holdings Inc (MEDP)
397.56
-9.59
(-2.36%)
USD |
NASDAQ |
Apr 24, 16:00
398.00
+0.44
(+0.11%)
After-Hours: 20:00
Medpace Holdings Total Liabilities (Quarterly): 1.124B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.124B |
| December 31, 2023 | 1.098B |
| September 30, 2023 | 1.016B |
| June 30, 2023 | 1.016B |
| March 31, 2023 | 1.048B |
| December 31, 2022 | 966.11M |
| September 30, 2022 | 978.54M |
| June 30, 2022 | 1.032B |
| March 31, 2022 | 739.33M |
| December 31, 2021 | 707.01M |
| September 30, 2021 | 679.06M |
| June 30, 2021 | 617.83M |
| March 31, 2021 | 592.43M |
| December 31, 2020 | 584.90M |
| September 30, 2020 | 504.51M |
| June 30, 2020 | 484.06M |
| March 31, 2020 | 419.84M |
| Date | Value |
|---|---|
| December 31, 2019 | 416.79M |
| September 30, 2019 | 380.32M |
| June 30, 2019 | 358.81M |
| March 31, 2019 | 384.62M |
| December 31, 2018 | 378.23M |
| September 30, 2018 | 388.45M |
| June 30, 2018 | 428.10M |
| March 31, 2018 | 461.95M |
| December 31, 2017 | 447.19M |
| September 30, 2017 | 398.63M |
| June 30, 2017 | 356.29M |
| March 31, 2017 | 345.11M |
| December 31, 2016 | 368.40M |
| September 30, 2016 | 365.95M |
| June 30, 2016 | 572.23M |
| March 31, 2016 | 576.13M |
| December 31, 2015 | 570.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
358.81M
Minimum
Jun 2019
1.124B
Maximum
Mar 2024
738.20M
Average
693.03M
Median
Total Liabilities (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 4.536B |
| Avid Bioservices Inc | 270.97M |
| Iovance Biotherapeutics Inc | 195.74M |
| Renovaro Inc | 14.42M |
| Candel Therapeutics Inc | 28.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.796B |
| Shareholders Equity (Quarterly) | 671.54M |
| Current Ratio | 0.7787 |
| Net Debt Paydown Yield | 0.08% |